Denmark· DK-28106993323

Canesten

A clotrimazole product containing clotrimazol, registered in Denmark by Orifarm A/S. The same ATC class is registered in 13 of our 19 countries.

ATC G01AF02

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedCanestenATCG01AF02REGISTER NO.DK-28106993323PACKS LISTED1CHECKEDSeptember 30, 2026

Where it is registered

Clotrimazole is registered in 13 of 19 countries.

Countries holding a registration under ATC G01AF02 (clotrimazole), each read from that country’s own register.

  • This record: Denmark, from Danish Medicines Agency (Denmark)
  • 7 of them publish a price we can compare per daily dose

Clotrimazole · ATC G01AF02

13 / 19 countries

  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
CLOTRIMAZOL
Manufacturer
Orifarm A/S
Country
Denmark (DK)
ATC code
G01AF02
ATC class
Clotrimazole
Defined daily dose
0.1 g, V
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28106993323

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

592 interactions on record for clotrimazole.

Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Clotrimazole · interactions on record

592 records

  • 35 severe
  • 240 moderate
  • 28 minor
  • 289 info

Most severe, free to view

  • EliglustatA16AX10severe
  • LonafarnibA16AX20severe
  • AmiodaroneC01BD01severe
  • IvabradineC01EB17severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cd5043e5-ba88-4a82-af3e-6e092420a465
GET /v1/drugs/cd5043e5-ba88-4a82-af3e-6e092420a465?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "vaginaltabletter og creme",
  "source": "dkma",
  "strength": "500 mg+10 mg/g",
  "auth_role": "DKMA",
  "dk_drugid": "28106993323",
  "substance": "CLOTRIMAZOL",
  "auth_procedure": "Par-Imp",
  "in_medicinpriser": false,
  "registration_date_serial": "45174"
}

See everything about clotrimazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.